The Department of Health and Social Care has today announced the second wave of price concessions for November.

The latest announcement (below), revealed by the PSNC, follows the first installment on November 21.

 

  • Allopurinol 100mg tablets 28 £2.20
  • Allopurinol 300mg tablets 28 £5.17
  • Brimonidine 0.2% eye drops 5 £2.30
  • Buprenorphine 2mg sublingual tablet sugar free 7 £5.19
  • Co-careldopa 25mg/100mg tablets 100 £10.00
  • Diamorphine 10mg powder for solution for injection ampoules 5 £15.20
  • Dosulepin 25mg capsules 28 £5.10
  • Hydroxocobalamin 1mg/1ml solution for injection ampoules 5 £10.00
  • Lercanidipine 10mg tablets 28 £4.78
  • Metronidazole 400mg tablets 21 £7.15
  • Naproxen 500mg gastro-resistant tablets 56 £10.99
  • Orlistat 120mg capsules 84 £24.19
  • Ranitidine 150mg tablets 60 £1.30
  • Sodium valproate 500mg gastro-resistant tablets 100 £16.24
  • Topiramate 50mg tablets 60 £11.15

Recommended

Interview: Jeremy Main

The Healthcare Distribution Association's first independent chair wants to give the organisation a vibrant voice.

PSNC to give LPCs more support next year

The PSNC has outlined three main topics which will drive its work next year.




This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Independent Pharmacist's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.